Reaction Details Report a problem with these data
Target
B-cell lymphoma 6 protein [5-129]
Ligand
BDBM522269
Substrate
n/a
Meas. Tech.
HTRF Assay
IC50
89.1±n/a nM
Citation
 Bellenie, BR; Cheung, KM; Davis, OA; Hoelder, S; Huckvale, R; Lloyd, MG 2-quinolone derived inhibitors of BCL6 US Patent  US11161839 Publication Date 11/2/2021 
Target
Name:
B-cell lymphoma 6 protein [5-129]
Synonyms:
BCL5 | BCL6 | BCL6_HUMAN | BTB domain-containing protein 27 (BCL-6)(5-129) | LAZ3 | ZBTB27 | ZNF51
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14310.07
Organism:
Homo sapiens (Human)
Description:
aa 5-129
Residue:
125
Sequence:
ADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE
  
Inhibitor
Name:
BDBM522269
Synonyms:
US11161839, Example 9g
Type:
Small organic molecule
Emp. Form.:
C21H15ClN6O3
Mol. Mass.:
434.835
SMILES:
Cn1c2ccc(Nc3cc(nc(Cl)c3C#N)C(O)=O)cc2c(NC2(CC2)C#N)cc1=O
Structure:
Search PDB for entries with ligand similarity: